Cationic lipid for nucleic acid delivery

US10092655B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10092655-B2
Application numberUS-201515504239-A
CountryUS
Kind codeB2
Filing dateAug 7, 2015
Priority dateAug 18, 2014
Publication dateOct 9, 2018
Grant dateOct 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a cationic lipid capable of achieving higher intracellular delivery efficiency than conventional cationic lipids, when used as a lipid membrane structure which is a carrier for delivering functional nucleic acid. The cationic lipid is represented by the formula (1): wherein each symbol is as defined herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cationic lipid represented by the formula (1): wherein any 4 of X 1 -X 6 are each independently a group represented by the formula (X a ), a group represented by the formula (X b ) or a hydroxyl group (provided that said 4 are not hydroxyl groups at the same time), and the remaining 2 are each independently a group represented by the formula (X c ) or a hydroxyl group (provided that said 2 are not hydroxyl groups at the same time)) —Y 1 —R 1   (X a ) wherein R 1 is an aliphatic hydrocarbon group having 8-22 carbon atoms or an acyl group having 8-22 carbon atoms; Y 1 is —O— or —NH—) wherein R 2 is a sterol residue or a liposoluble vitamin residue; Z 1 is an alkylene group having 2 or 3 carbon atoms; Y 2 is —O—CO— or —NH—CO—) wherein R 3 and R 4 are each independently an alkyl group having 1-6 carbon atoms, R 3 and R 4 are optionally bonded to form a ring; Z 2 is an alkylene group having 1-6 carbon atoms; Y 3 is —O—, —O—CO— or —NH—CO—; n is 0 or 1. 2. The cationic lipid according to claim 1 , wherein any 4 of X 1 -X 6 are each independently a group represented by the formula (X a ) or a group represented by the formula (X b ), and the remaining 2 are each independently a group represented by the formula (X c ). 3. The cationic lipid according to claim 1 , wherein any 4 of X 1 -X 6 are each independently a group represented by the formula (X a ), and the remaining 2 are each independently a group represented by the formula (X c ). 4. The cationic lipid according to claim 1 , wherein R 1 is an aliphatic hydrocarbon group having 10-20 carbon atoms or an acyl group having 10-20 carbon atoms. 5. The cationic lipid according to claim 1 , wherein R 1 is an aliphatic hydrocarbon group having an unsaturated bond and 10-20 carbon atoms or an acyl group having 10-20 carbon atoms. 6. The cationic lipid according to claim 1 , wherein Y 1 is —O—. 7. The cationic lipid according to claim 1 , wherein any 4 of X 1 -X 6 are each independently a group represented by the formula (X b ), and the remaining 2 are each independently a group represented by the formula (X c ). 8. A lipid membrane structure comprising the cationic lipid according to claim 1 . 9. A nucleic acid-introducing agent comprising the lipid membrane structure according to claim 8 and a nucleic acid.

Assignees

Inventors

Classifications

  • to carbon atoms of acyclic carbon skeletons · CPC title

  • Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title

  • Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)} · CPC title

  • A61K47/543Primary

    Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine · CPC title

  • Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10092655B2 cover?
The invention provides a cationic lipid capable of achieving higher intracellular delivery efficiency than conventional cationic lipids, when used as a lipid membrane structure which is a carrier for delivering functional nucleic acid. The cationic lipid is represented by the formula (1): …
Who is the assignee on this patent?
Nof Corp, Univ Hokkaido Nat Univ Corp
What technology area does this patent fall under?
Primary CPC classification A61K47/543. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).